Methodist Journal

FEATURED GUEST EDITOR

ISSUE INTRO

The Scourge of Cardiogenic Shock

See More
RECOGNITIONS

Arvind Bhimaraj, MD, MPH, Guides Issue on Cardiogenic Shock

See More

REVIEW ARTICLES See More

Cardiovascular Implications of COVID-19 Infections

Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic Shock

Cardiogenic Shock in the Setting of Acute Myocardial Infarction

Cardiogenic Shock in Patients with Advanced Chronic Heart Failure

Acute Mechanical Circulatory Support for Cardiogenic Shock

Management of Cardiogenic Shock in a Cardiac Intensive Care Unit

Physiological Concepts of Cardiogenic Shock Using Pressure-Volume Loop Simulations: A Case-Based Review

Systems of Care in Cardiogenic Shock

CASE REPORTS See More

COVID-19: A Potential Risk Factor for Acute Pulmonary Embolism

Repair of Extent III Thoracoabdominal Aneurysm in the Presence of Aortoiliac Occlusion

Williams-Beuren Syndrome: The Role of Cardiac CT in Diagnosis

A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

A T2-Weighty Discovery: Aortitis on Cardiac MRI with Histopathologic Correlation

CLINICAL PERSPECTIVES See More

POINTS TO REMEMBER

Acute Kidney Injury in Cardiogenic Shock

EXCERPTA

Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg

POINTS TO REMEMBER

Onconephrology: An Evolving Field

POINTS TO REMEMBER

Herbal Nephropathy

EDITORIALS

Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 16, Issue 1 (2020)

Search Keywords

Showing results for keyword “prevention”

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Monica Avila   Vol 15, Issue 4

Keywords: cancer , cardiotoxicity , prevention , treatment , chemotherapy , heart disease , anthracyclines , cardio-oncology

Avila MS, Siqueira SRR, Ferreira SMA, Bocchi EA. Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity. Methodist DeBakey Cardiovasc J. 2019;15(4):267-73.

Prediabetes: Why Should We Care?

Ashkan Zand   Vol 14, Issue 4

Keywords: prediabetes , impaired fasting glucose , impaired glucose tolerance , diabetes prevention , management of prediabetes

Zand A, Ibrahim K, Patham B. Prediabetes: Why Should We Care? Methodist DeBakey Cardiovasc J. 2018;14(4):289-97.

Telomerase Therapy to Reverse Cardiovascular Senescence

Timo Z. Nazari-Shafti   Vol 11, Issue 3

Keywords: telomerase , cellular senescence , endothelium , atherosclerosis , prevention , modified MRNA , aging

Timo Z. Nazari-Shafti and John P. Cooke. Telomerase Therapy to Reverse Cardiovascular Senescence. Methodist DeBakey Cardiovascular Journal. September 2015, Vol. 11, No. 3, pp. 172-175.

The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation

Basel Ramlawi   Vol 11, Issue 2

Keywords: left atrial appendage , atrial fibrillation , LAA exclusion , stroke prevention

Basel Ramlawi, Walid K. Abu Saleh, and James Edgerton. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation. Methodist DeBakey Cardiovascular Journal. April 2015, Vol. 11, No. 2, pp. 100-103.